The Dawn of Disease-Modifying Therapies: Navigating the Complex Evolution of the Global Alzheimer’s and Parkinson’s Treatment Landscape
Revolutionizing Neuro-Care Through Biomarker Discovery For decades, the medical community viewed neurodegenerative diseases as inevitable regressions of the human nervous system. However, the last five years have ushered in a paradigm shift, moving from symptomatic management to disease-modifying interventions. The identification of specific biomarkers—such as phosphorylated tau in blood...
0 Comments 0 Shares 122 Views 0 Reviews